Sobre Codexis, Inc. - Common Stock Visão geral da empresa da Wikipedia

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Ler mais

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

History

Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.

Pharmaceutical

Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.

Nutrition

In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.

Biotherapeutics

In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.

In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.

Life science

In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.

Technology

Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

CDXS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço

$1.56

Capitalização de Mercado

$142M

P/E (TTM)

-3.1

EPS (TTM)

$-0.50

Receita (TTM)

$70M

Rendimento div.

—

ROE

-82.8%

Dívida/Capital

0.8

Intervalo 52 Semanas

$1 – $3

CDXS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $70M

2016-12-31 → 2025-12-31

EPS $-0.50

2019-12-31 → 2025-12-31

Fluxo de caixa livre $-24M

2016-12-31 → 2025-12-31

Margens -62.5%

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

P/E (TTM)

-3.1

17.5

P/S (TTM)

2.0

3.3

P/B

2.8

2.1

EV / EBITDA

-2.8

—

Price / FCF (Preço / FCF)

-5.9

—

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

Operating Margin (Margem Operacional)

-59.3%

—

Net Profit Margin (Margem de Lucro Líquido)

-62.5%

-56.5%

ROA

-29.6%

-17.2%

ROE

-82.8%

-41.3%

ROIC

-46.1%

—

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

Debt / Equity (Dívida / Patrimônio Líquido)

0.8

369.6

Current Ratio (Índice de liquidez corrente)

3.8

4.9

Quick Ratio (Índice de Liquidez Seca)

3.1

—

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

Revenue YoY (Receita Ano a Ano)

18.6%

—

Revenue CAGR 3Y (CAGR Receita 3A)

-20.2%

—

Revenue CAGR 5Y (CAGR Receita 5A)

0.38%

—

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

EPS (Diluted) (EPS (Diluído))

$-0.50

—

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica

Tendência de 5 anos

CDXS

Mediana de Pares

CDXS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

COMPRA 13 analistas

Compra forte 4 30,8%
Compra 6 46,2%
Manter 3 23,1%
Venda 0 0,0%
Venda forte 0 0,0%

Preço-alvo de 12 meses

6 analistas · 2026-08-13

Mediana $7.00

← Abaixo de todos os alvos $1.56

Mín $2.00

Máx $11.00

Alvo mediano $7.00 +347,3%

Alvo médio $6.58 +320,7%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média

0.01%

Período	EPS Actual	EPS est.	Surpresa
30 de Junho de 2026	$-0.13	$-0.14	0.01%
31 de Março de 2026	$-0.10	$-0.14	0.04%
31 de Dezembro de 2025	$0.11	$-0.04	0.15%
30 de Setembro de 2025	$-0.22	$-0.15	-0.07%
30 de Junho de 2025	$-0.16	$-0.19	0.03%
31 de Março de 2025	$-0.25	$-0.24	-0.01%
31 de Dezembro de 2024	$-0.13	$-0.04	-0.09%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker	Capitalização de Mercado	P/E	Receita YoY	Margem Líquida	ROE	Margem Bruta
CDXS	$147M	-3.3	18.6%	-62.5%	-82.8%	—
DNA	$484M	-1.5	-25.1%	-183.8%	-55.8%	—
TKNO	$204M	-11.9	7.3%	-42.6%	-23.8%	33.2%
PACB	$565M	-1.0	3.9%	-341.5%	-1634.9%	28.6%
LAB	$495M	-6.4	-6.2%	-87.8%	-17.6%	49.9%
LFCR	$249M	-5.3	0.47%	-30.0%	-461.3%	31.3%
QSI	—	—	—	—	—	—
MXCT	$166M	-3.7	-14.5%	-135.1%	-24.6%	81.2%
QTRX	$297M	-2.5	1.1%	-77.1%	-36.4%	46.8%
SEER	—	-1.4	17.0%	—	—	—
NAUT	$247M	-4.1	—	—	-34.9%	—

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 16

Dados anuais de Demonstração de Resultados para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Cost of Revenue	$9M	$16M	$13M	$38M	$22M	$14M	$16M	$13M	$14M	$10M	$7M	$10M
R&D Expense	$52M	$46M	$59M	$80M	$56M	$44M	$34M	$30M	$30M	$22M	$21M	$23M
SG&A Expense	$47M	$55M	$53M	$52M	$49M	$35M	$32M	$29M	$29M	$25M	$22M	$22M
Operating Expenses	$112M	$118M	$138M	$173M	$127M	$93M	$81M	$72M	$73M	$57M	$50M	$54M
Operating Income	$-42M	$-59M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M
Interest Income	$3M	$4M	$4M	$1M	$459.0K	$405.0K	$1M	$671.0K	$147.0K	$60.0K	$19.0K	$18.0K
Other Non-op	$-5M	$-10M	$-12M	$124.0K	$1M	$-156.0K	$-656.0K	$-291.0K	$-92.0K	$-94.0K	·	·
Pretax Income	$-44M	$-65M	$-76M	$-33M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Income Tax	$47.0K	$34.0K	$69.0K	$276.0K	$189.0K	$339.0K	$17.0K	$-37.0K	$81.0K	$-40.0K	$-338.0K	$-256.0K
Net Income	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
EPS (Basic)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
EPS (Diluted)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·
Shares (Basic)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
Shares (Diluted)	87,142,000	73,408,000	68,131,000	65,344,000	64,568,000	59,360,000	56,525,000	·	·	·	·	·
EBITDA	$-36M	$-54M	$-68M	$-35M	$-23M	$-24M	$-13M	$-11M	$-23M	$-9M	$-8M	$-19M

Balanço Patrimonial 29

Dados anuais de Balanço Patrimonial para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$51M	$19M	$65M	$114M	$117M	$149M	$90M	$53M	$31M	$19M	$23M	$26M
Short-term Investments	$27M	$54M	$0	·	·	·	·	·	·	·	·	·
Receivables	·	·	$10M	$32M	$25M	$14M	$9M	$12M	$11M	$6M	$7M	$4M
Inventory	$2M	$2M	$3M	$2M	$1M	$964.0K	$371.0K	$589.0K	$1M	$825.0K	$992.0K	$1M
Prepaid Expense	$6M	$4M	$5M	$5M	$6M	$3M	$3M	$1M	$984.0K	$1M	$1M	$1M
Other Current Assets	$500.0K	$500.0K	$600.0K	$700.0K	·	·	·	·	·	·	·	·
Current Assets	$97M	$99M	$93M	$163M	$162M	$184M	$114M	$68M	$45M	$27M	$33M	$33M
PP&E (Net)	$13M	$14M	$15M	$23M	$21M	$10M	$6M	$5M	$3M	$2M	$3M	$4M
PP&E (Gross)	$58M	$55M	$55M	$62M	$57M	$43M	$40M	$38M	$35M	$34M	$35M	$37M
Accum. Depreciation	$45M	$41M	$39M	$40M	$36M	$33M	$33M	$33M	$32M	$32M	$32M	$31M
Goodwill	$2M	$2M	$2M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Intangibles	·	·	·	·	·	·	·	·	·	$0	$3M	$6M
Other Non-current Assets	$883.0K	$1M	$1M	$350.0K	$276.0K	$294.0K	$178.0K	$1M	$302.0K	$259.0K	$310.0K	$294.0K
Total Assets	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Accounts Payable	$2M	$3M	$6M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$5M
Accrued Liabilities	$3M	$6M	$5M	$15M	$13M	$10M	$7M	$5M	$4M	$2M	$2M	$3M
Current Liabilities	$25M	$24M	$36M	$49M	$33M	$25M	$15M	$18M	$25M	$12M	$15M	$14M
Capital Leases	$30M	$28M	$12M	$38M	$44M	$22M	$25M	$61.0K	$302.0K	·	·	·
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$3M
Total Liabilities	$97M	$82M	$50M	$106M	$82M	$52M	$44M	$23M	$29M	$17M	$22M	·
Long-term Debt	$40M	$29M	·	·	·	·	·	·	·	·	·	·
Total Debt	$40M	$29M	·	·	·	·	·	·	$302.0K	·	·	·
Common Stock	$9.0K	$8.0K	$7.0K	$6.0K	$6.0K	$6.0K	$6.0K	$5.0K	$5.0K	$4.0K	$4.0K	$4.0K
Paid-in Capital	$657M	$630M	$584M	$566M	$552M	$537M	$448M	$387M	$340M	$311M	$306M	$302M
Retained Earnings	$-607M	$-563M	$-498M	$-421M	$-388M	$-366M	$-342M	$-330M	$-315M	$-292M	$-284M	$-276M
AOCI	$8.0K	$52.0K	$0	·	·	·	·	$0	$-472.0K	$0	$405.0K	$-142.0K
Stockholders' Equity	$51M	$67M	$87M	$145M	$164M	$170M	$106M	$56M	$25M	$19M	$23M	$26M
Liabilities + Equity	$148M	$149M	$137M	$250M	$246M	$222M	$149M	$79M	$54M	$36M	$45M	$48M
Shares Outstanding	90,478,000	81,850,000	69,905,000	65,811,000	65,109,000	64,283,000	58,877,000	54,065,000	48,365,000	41,255,000	40,343,000	39,563,000

Fluxo de Caixa 17

Dados anuais de Fluxo de Caixa para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$5M	$5M	$6M	$5M	·	·	·	·	·	·	·	·
Stock-based Comp	$10M	$13M	$10M	$15M	$12M	$8M	$7M	$8M	$7M	$6M	$5M	$5M
Deferred Tax	$-3.0K	$-2.0K	$0	$-7.0K	$-9.0K	$-8.0K	$-6.0K	$-29.0K	$12.0K	$-31.0K	$-330.0K	$110.0K
Amort. of Intangibles	·	·	·	·	·	·	·	$0	$0	$3M	$3M	$3M
Restructuring	$3M	$0	$3M	$3M	$0	$0	·	·	·	·	·	·
Other Non-cash	$10M	$-2M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-19M	$-49M	$-53M	$11M	$-14M	$-16M	$-13M	$-14M	$-9M	$-2M	$-433.0K	$321.0K
CapEx	$4M	$4M	$4M	$8M	$14M	$4M	$4M	$3M	$985.0K	$888.0K	$1M	$302.0K
Investing Cash Flow	$24M	$-57M	$-5M	$-14M	$-21M	$-6M	$-4M	$-3M	$-983.0K	$-846.0K	$-1M	$5M
Debt Issued	$10M	$30M	$0	$0	·	·	·	·	·	·	·	·
Net Debt Issued	$10M	$30M	·	·	·	·	·	·	·	·	·	·
Stock Issued	$17M	$31M	$9M	$0	$0	$86M	$0	$37M	$24M	$0	$0	$9.0K
Net Stock Activity	$17M	$31M	$9M	$0	$0	$86M	$50M	·	$24M	$0	$0	$9.0K
Financing Cash Flow	$28M	$61M	$8M	$-575.0K	$4M	$81M	$54M	$39M	$22M	$-490.0K	$-2M	$-611.0K
Net Change in Cash	$32M	$-46M	$-49M	$-3M	$-32M	$59M	$38M	$22M	$12M	$-3M	$-3M	$4M
Taxes Paid	·	$17.0K	$194.0K	$100.0K	$102.0K	$312.0K	$5.0K	$5.0K	$32.0K	$5.0K	$8.0K	$15.0K
Free Cash Flow	$-24M	$-54M	$-57M	$3M	$-28M	$-20M	$-16M	$-17M	$-10M	$-4M	$-2M	$19.0K

Lucratividade 7

Dados anuais de Lucratividade para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
Net Margin	-62.5%	-110.0%	-108.7%	-24.2%	-20.3%	-34.8%	-17.4%	-17.9%	-46.0%	-17.5%	-18.1%	-54.0%
Pretax Margin	-62.4%	-109.9%	-108.6%	-24.0%	-20.1%	-34.3%	-17.4%	-18.0%	-45.8%	-17.6%	-18.9%	-54.7%
EBITDA Margin	-51.8%	-90.3%	-97.0%	-25.2%	-21.7%	-34.6%	-18.3%	-18.6%	-45.9%	-17.5%	-18.6%	-54.1%
ROA	-29.6%	-45.7%	-39.4%	-13.5%	-9.1%	-13.0%	-10.4%	-16.4%	-51.5%	-21.3%	-16.3%	-35.7%
ROE	-82.8%	-93.0%	-85.6%	-22.5%	-12.8%	-18.4%	-11.5%	-19.6%	-98.6%	-40.8%	-30.8%	-56.3%
ROIC	-46.1%	-61.1%	-78.7%	-24.3%	-13.9%	-14.3%	-11.9%	-20.0%	-92.8%	-44.6%	-32.5%	-71.7%

Liquidez e Solvência 4

Dados anuais de Liquidez e Solvência para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	3.8	4.2	2.6	3.3	4.9	7.4	7.4	3.8	1.8	2.2	2.2	2.4
Quick Ratio	3.1	3.1	2.1	3.0	4.2	6.5	6.5	3.6	1.7	2.0	2.1	2.2
Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·
LT Debt / Equity	0.8	0.4	·	·	·	·	·	·	0.0	·	·	·

Eficiência 3

Dados anuais de Eficiência para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.4	0.4	0.6	0.4	0.4	0.6	0.9	1.1	1.2	0.9	0.7
Inventory Turnover	5.2	7.3	5.4	23.9	20.9	20.6	32.6	15.5	15.4	10.7	5.5	6.7
Receivables Turnover	·	·	3.3	4.9	5.4	6.0	6.7	5.3	5.6	7.4	7.5	7.6

Por Ação 5

Dados anuais de Por Ação para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.56	$0.82	$1.24	$2.20	$2.52	$2.65	$1.79	$1.03	$0.51	$0.46	$0.57	$0.67
Revenue / Share	$0.81	$0.81	$1.03	$2.12	$1.62	·	·	·	·	·	·	·
Cash Flow / Share	$-0.22	$-0.67	$-0.77	$0.17	$-0.22	·	·	·	·	·	·	·
Cash / Share	$0.56	$0.24	$0.93	$1.73	$1.79	$2.32	$1.54	$0.97	$0.65	$0.47	$0.58	$0.67
EPS (TTM)	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33	$-0.40	$-0.21	·	·	·	·	·

Taxas de Crescimento 3

Dados anuais de Taxas de Crescimento para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	18.6%	-15.4%	-49.4%	32.3%	51.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-20.2%	-17.3%	0.52%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	0.38%	·	·	·	·	·	·	·	·	·	·	·

Avaliação (TTM) 14

Dados anuais de Avaliação (TTM) para CDXS
Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$70M	$59M	$70M	$139M	$105M	$69M	$68M	$61M	$50M	$49M	$42M	$35M
Net Income TTM	$-44M	$-65M	$-76M	$-34M	$-21M	$-24M	$-12M	$-11M	$-23M	$-9M	$-8M	$-19M
Market Cap	$147M	$390M	$213M	$307M	$2.04B	$1.40B	$941M	$912M	$404M	$190M	$171M	$100M
Enterprise Value	$109M	$346M	·	·	·	·	·	·	$373M	·	·	·
P/E	-3.3	-5.4	-2.7	-9.1	-94.8	-54.6	-76.1	·	·	·	·	·
P/S	2.1	6.6	3.0	2.2	19.4	20.3	13.8	15.0	8.1	3.9	4.1	2.8
P/B	2.9	5.8	2.5	2.1	12.4	8.2	8.9	16.2	16.5	9.9	7.5	3.8
P / Tangible Book	3.1	6.1	2.5	2.2	12.6	8.4	·	·	·	·	·	·
P / Cash Flow	-7.6	-7.9	-4.1	27.2	-142.7	-85.2	-75.0	-64.7	-46.1	-70.3	-394.1	310.6
P / FCF	-6.2	-7.3	-3.7	103.0	-72.5	-69.4	-57.8	-54.1	-41.4	-52.9	-104.6	5247.3
EV / EBITDA	-3.0	-6.5	·	·	·	·	·	·	-16.2	·	·	·
EV / FCF	-4.6	-6.4	·	·	·	·	·	·	-38.3	·	·	·
EV / Revenue	1.6	5.8	·	·	·	·	·	·	7.5	·	·	·
Earnings Yield	-30.7%	-18.7%	-36.7%	-10.9%	-1.1%	-1.8%	-1.3%	·	·	·	·	·

Demonstração de Resultados 16

Dados trimestrais de Demonstração de Resultados para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$15M	$15M	$39M	$9M	$15M	$8M	$21M	$13M	$8M	$17M	$27M	$9M	$21M	$13M	$30M	$34M
Cost of Revenue	$4M	$2M	$2M	$2M	$2M	$3M	$4M	$4M	$3M	$5M	$3M	$2M	$3M	$5M	$8M	$10M
R&D Expense	$12M	$11M	$12M	$14M	$14M	$13M	$12M	$12M	$11M	$11M	$11M	$14M	$17M	$17M	$20M	$22M
SG&A Expense	$11M	$10M	$11M	$11M	$12M	$12M	$13M	$14M	$16M	$13M	$12M	$12M	$13M	$15M	$12M	$13M
Operating Expenses	$26M	$23M	$28M	$28M	$28M	$28M	$29M	$29M	$31M	$29M	$26M	$41M	$34M	$37M	$44M	$45M
Operating Income	$-11M	$-8M	$11M	$-19M	$-13M	$-20M	$-7M	$-17M	$-23M	$-12M	$282.0K	$-32M	$-13M	$-24M	$-13M	$-11M
Interest Income	$535.0K	$665.0K	$656.0K	$634.0K	$584.0K	$751.0K	$940.0K	$849.0K	$972.0K	$909.0K	$906.0K	$1M	$1M	$1M	$823.0K	$436.0K
Other Non-op	$-1M	$-1M	$-2M	$-1M	$-984.0K	$-942.0K	$-4M	$-5M	$-985.0K	$-516.0K	$-8M	$-4M	$-9.0K	$-25.0K	$-26.0K	$216.0K
Pretax Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-11M	$-7M	$-35M	$-12M	$-23M	$-12M	$-10M
Income Tax	$10.0K	$36.0K	$18.0K	$8.0K	$10.0K	$11.0K	$4.0K	$10.0K	$10.0K	$10.0K	$35.0K	$9.0K	$9.0K	$16.0K	$151.0K	$8.0K
Net Income	$-12M	$-9M	$10M	$-20M	$-13M	$-21M	$-10M	$-21M	$-23M	$-12M	$-7M	$-35M	$-12M	$-23M	$-13M	$-10M
EPS (Basic)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
EPS (Diluted)	$-0.13	$-0.10	$0.13	$-0.22	$-0.16	$-0.25	$-0.12	$-0.29	$-0.32	$-0.16	$-0.11	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15
Shares (Basic)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
Shares (Diluted)	91,053,000	90,768,000	-170,908,000	90,251,000	85,389,000	82,410,000	-138,854,000	72,032,000	70,376,000	69,854,000	-134,839,000	69,466,000	67,573,000	65,931,000	-130,466,000	65,426,000
EBITDA	$-11M	·	·	$-19M	$-13M	$-19M	·	$-17M	$-23M	$-12M	·	$-32M	$-13M	$-24M	·	$-11M

Balanço Patrimonial 27

Dados trimestrais de Balanço Patrimonial para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$27M	$37M	$51M	$25M	$27M	$18M	$19M	$37M	$19M	$58M	$65M	$75M	$92M	$103M	$114M	$109M
Short-term Investments	$28M	$29M	$27M	$33M	$40M	$41M	$54M	$53M	$55M	$27M	·	·	·	·	·	·
Inventory	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$2M	$2M	·	$2M
Prepaid Expense	$3M	$4M	$6M	$5M	$3M	$4M	$4M	$3M	$3M	$5M	·	$5M	$4M	$5M	·	$5M
Other Current Assets	$500.0K	$400.0K	$500.0K	$500.0K	$100.0K	$500.0K	$500.0K	$300.0K	$900.0K	$500.0K	·	·	·	·	·	·
Current Assets	$72M	$80M	$97M	$76M	$89M	$78M	$99M	$113M	$91M	$108M	·	$103M	$120M	$130M	·	$146M
PP&E (Net)	$12M	$13M	$13M	$14M	$15M	$16M	$14M	$13M	$14M	$15M	·	$15M	$23M	$24M	·	$23M
PP&E (Gross)	$59M	$59M	$58M	$58M	$58M	$57M	$55M	$54M	$54M	$55M	·	$54M	$66M	$65M	·	$63M
Accum. Depreciation	$47M	$46M	$45M	$44M	$43M	$42M	$41M	$41M	$40M	$40M	·	$39M	$42M	$41M	·	$39M
Goodwill	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·	$2M	$3M	$3M	$3M	$3M
Other Non-current Assets	$1M	$994.0K	$883.0K	$912.0K	$950.0K	$967.0K	$1M	$2M	$2M	$1M	·	$726.0K	$498.0K	$415.0K	·	$208.0K
Total Assets	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Accounts Payable	$3M	$2M	$2M	$2M	$1M	$6M	$3M	$4M	$4M	$3M	·	$3M	$4M	$4M	·	$3M
Accrued Liabilities	$3M	$3M	$3M	$3M	$3M	$5M	$6M	$7M	$5M	$5M	·	$9M	$7M	$8M	·	$13M
Current Liabilities	$24M	$15M	$25M	$18M	$15M	$21M	$24M	$35M	$31M	$29M	·	$38M	$36M	$38M	·	$32M
Capital Leases	$28M	$29M	$30M	$26M	$27M	$27M	$28M	$9M	$10M	$11M	·	$13M	$35M	$37M	·	$40M
Other Non-current Liabilities	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	$1M	$1M	$1M	·	$1M
Total Liabilities	$87M	$86M	$97M	$85M	$83M	$79M	$82M	$75M	$71M	$70M	·	$63M	$83M	$92M	·	$81M
Long-term Debt	$41M	$40M	$40M	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Total Debt	$41M	·	·	$40M	$39M	$29M	·	$29M	$28M	$28M	·	·	·	·	·	·
Common Stock	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$8.0K	$7.0K	$7.0K	·	$6.0K	$6.0K	$6.0K	·	$6.0K
Paid-in Capital	$660M	$659M	$657M	$655M	$652M	$633M	$630M	$626M	$593M	$588M	·	$582M	$580M	$570M	·	$563M
Retained Earnings	$-627M	$-615M	$-607M	$-616M	$-597M	$-583M	$-563M	$-552M	$-532M	$-509M	·	$-490M	$-455M	$-444M	·	$-409M
AOCI	$-13.0K	$-11.0K	$8.0K	$12.0K	$-3.0K	$14.0K	$52.0K	$126.0K	$-23.0K	$-16.0K	·	·	·	·	·	·
Stockholders' Equity	$33M	$43M	$51M	$39M	$56M	$50M	$67M	$73M	$61M	$79M	$87M	$92M	$124M	$126M	$145M	$154M
Liabilities + Equity	$120M	$129M	$148M	$124M	$138M	$129M	$149M	$148M	$132M	$150M	·	$154M	$207M	$218M	·	$235M
Shares Outstanding	91,388,000	90,894,000	90,478,000	90,281,000	90,254,000	82,841,000	81,850,000	81,376,000	70,914,000	70,554,000	·	69,827,000	69,804,000	66,696,000	·	65,613,000

Fluxo de Caixa 15

Dados trimestrais de Fluxo de Caixa para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	·	·	·
Stock-based Comp	$2M	$1M	$2M	$3M	$3M	$2M	$3M	$3M	$5M	$3M	$2M	$2M	$3M	$3M	$3M	$5M
Restructuring	·	·	·	·	·	·	$0	$0	$0	$0	$0	$3M	$72.0K	$72.0K	$3M	$0
Other Non-cash	·	·	·	·	·	$3M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-10M	$-13M	$20M	$-8M	$-18M	$-14M	$-16M	$-13M	$-12M	$-8M	$-11M	$-16M	$-16M	$-9M	$5M	$20M
CapEx	$898.0K	$176.0K	$520.0K	$182.0K	$3M	$1M	$2M	$1M	$395.0K	$1M	$-380.0K	$678.0K	$2M	$3M	$-33.0K	$1M
Investing Cash Flow	$175.0K	$-1M	$6M	$6M	$-367.0K	$12M	$-3M	$2M	$-27M	$-29M	$1M	$-1M	$-2M	$-3M	$33.0K	$-1M
Debt Issued	·	·	$0	$0	$10M	$0	$0	$0	$0	$30M	$0	$0	$0	$0	·	·
Net Debt Issued	·	·	·	·	·	$0	·	·	·	$30M	·	·	·	·	·	·
Stock Issued	·	·	$-1.0K	$0	·	·	$-1.0K	$31M	$0	$0	$0	$0	$7M	$2M	$0	$0
Net Stock Activity	·	·	·	·	·	·	·	·	·	$0	·	·	·	$2M	·	·
Financing Cash Flow	$66.0K	$-14.0K	$180.0K	$-111.0K	$27M	$1M	$1M	$30M	$-197.0K	$29M	$0	$-108.0K	$7M	$1M	$339.0K	$133.0K
Net Change in Cash	$-9M	$-14M	$26M	$-1M	$8M	$-944.0K	$-18M	$19M	$-39M	$-7M	$-10M	$-18M	$-11M	$-11M	$5M	$19M
Taxes Paid	·	·	·	·	·	$0	·	·	·	$17.0K	·	·	·	·	·	·
Free Cash Flow	·	·	·	·	·	$-15M	·	·	·	$-9M	·	·	·	$-12M	·	·

Lucratividade 7

Dados trimestrais de Lucratividade para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-75.3%	·	·	-220.3%	-83.9%	-271.6%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
Net Margin	-80.5%	·	·	-228.1%	-86.6%	-274.3%	·	-160.8%	-285.2%	-67.4%	·	-376.3%	-54.0%	-174.2%	·	-29.0%
Pretax Margin	-80.4%	·	·	-228.0%	-86.5%	-274.1%	·	-160.8%	-285.1%	-67.3%	·	-376.2%	-54.0%	-174.1%	·	-29.0%
EBITDA Margin	-75.3%	·	·	-220.3%	-83.9%	-255.8%	·	-129.0%	-284.9%	-69.6%	·	-345.6%	-59.2%	-182.3%	·	-30.9%
ROA	-9.3%	·	·	-14.4%	-9.8%	-14.9%	·	-13.6%	-13.4%	-6.3%	·	-17.9%	-5.2%	-10.0%	·	-4.3%
ROE	-27.1%	·	·	-35.0%	-22.7%	-32.1%	·	-25.0%	-24.5%	-11.2%	·	-28.4%	-8.1%	-15.9%	·	-6.2%
ROIC	-15.2%	·	·	-24.2%	-13.6%	-26.0%	·	-16.2%	-25.3%	-11.1%	·	-35.0%	-10.2%	-18.8%	·	-6.9%

Liquidez e Solvência 4

Dados trimestrais de Liquidez e Solvência para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.1	·	·	4.1	5.8	3.7	·	3.2	3.0	3.7	·	2.7	3.4	3.4	·	4.6
Quick Ratio	2.3	·	·	3.2	4.4	2.9	·	2.6	2.4	2.9	·	1.9	2.6	2.7	·	3.4
Debt / Equity	1.2	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·
LT Debt / Equity	1.0	·	·	1.0	0.7	0.6	·	0.4	0.5	0.4	·	·	·	·	·	·

Eficiência 2

Dados trimestrais de Eficiência para CDXS
Métrica	Tendência	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.1	·	·	0.1	0.1	0.1	·	0.1	0.0	0.1	·	0.0	0.1	0.1	·	0.1
Inventory Turnover		2.0	·	·	1.2	1.0	1.3	·	2.0	1.6	2.2	·	1.1	1.7	2.5	·	7.2

Por Ação 5

Dados trimestrais de Por Ação para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.36	·	·	$0.43	$0.62	$0.60	·	$0.90	$0.87	$1.12	·	$1.31	$1.78	$1.89	·	$2.35
Revenue / Share	$0.16	·	·	$0.10	$0.18	$0.09	·	$0.18	$0.11	$0.24	·	$0.13	$0.32	$0.20	·	$0.53
Cash Flow / Share	·	·	·	·	·	$-0.17	·	·	·	$-0.11	·	·	·	$-0.14	·	·
Cash / Share	$0.30	·	·	$0.28	$0.30	$0.22	·	$0.46	$0.26	$0.82	·	$1.07	$1.32	$1.54	·	$1.66
EPS (TTM)	$-0.61	$-0.73	·	$-0.92	$-1.02	$-1.02	·	$-1.27	$-1.15	$-1.17	·	$-1.16	$-0.70	$-0.66	·	$-0.29

Avaliação (TTM) 14

Dados trimestrais de Avaliação (TTM) para CDXS
Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$47M	·	$44M	$44M	$45M	·	$47M	$56M	$61M	·	$78M	$107M	$121M	·	$145M
Net Income TTM	$-54M	$-62M	·	$-74M	$-77M	$-76M	·	$-90M	$-81M	$-81M	·	$-79M	$-47M	$-44M	·	$-19M
Market Cap	$207M	·	·	$220M	$220M	$223M	·	$251M	$220M	$246M	·	$132M	$195M	$276M	·	$398M
Enterprise Value	$192M	·	·	$201M	$193M	$192M	·	$189M	$175M	$189M	·	·	·	·	·	·
P/E	-3.7	-2.2	·	-2.7	-2.4	-2.6	·	-2.4	-2.7	-3.0	·	-1.6	-4.0	-6.3	·	-20.9
P/S	3.8	·	·	5.0	5.0	4.9	·	5.3	4.0	4.1	·	1.7	1.8	2.3	·	2.7
P/B	6.3	·	·	5.7	4.0	4.5	·	3.4	3.6	3.1	·	1.4	1.6	2.2	·	2.6
P / Tangible Book	6.8	3.6	·	6.1	4.1	4.7	·	3.5	3.7	3.2	·	1.5	1.6	2.2	·	2.6
P / Cash Flow	·	·	·	·	·	-16.2	·	·	·	-31.6	·	·	·	-30.0	·	·
P / FCF	·	·	·	·	·	-14.8	·	·	·	-27.6	·	·	·	-23.5	·	·
EV / EBITDA	-17.1	·	·	-10.6	-15.0	-10.0	·	-11.4	-7.7	-15.9	·	·	·	·	·	·
EV / FCF	·	·	·	·	·	-12.8	·	·	·	-21.2	·	·	·	·	·	·
EV / Revenue	3.6	·	·	4.5	4.4	4.2	·	4.0	3.1	3.1	·	·	·	·	·	·
Earnings Yield	-27.0%	-44.8%	·	-37.7%	-41.8%	-37.9%	·	-41.2%	-37.1%	-33.5%	·	-61.4%	-25.0%	-15.9%	·	-4.8%

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Receita	$70M	$59M	$70M	$139M	$105M
Margem Operacional %	-59.3%	-98.6%	-97.0%	-25.2%	-21.7%
Lucro líquido	$-44M	$-65M	$-76M	$-34M	$-21M
EPS Diluído	$-0.50	$-0.89	$-1.12	$-0.51	$-0.33

Balanço Patrimonial

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dívida / Patrimônio Líquido	0.8	0.4	—	—	—
Índice de liquidez corrente	3.8	4.2	2.6	3.3	4.9
Índice de Liquidez Seca	3.1	3.1	2.1	3.0	4.2

Fluxo de Caixa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Fluxo de caixa livre	$-24M	$-54M	$-57M	$3M	$-28M

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 156 declarantes · $120.9M total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior

Novas posições	Posições encerradas	Aumentou	Diminuído	Variação líquida de ações
32 (+4 vs trimestre anterior)	11 (-10 vs trimestre anterior)	50 (+4 vs trimestre anterior)	41 (+8 vs trimestre anterior)	+6.7M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição	Valor	Ações	% de 13F rastreado	Tipo
Opaleye Management Inc.	$15.334.100	6.785.000	12,69%	Ações
Aberdeen Group plc	$15.300.096	6.769.954	12,66%	Ações
MILLENNIUM MANAGEMENT LLC	$12.541.054	5.549.139	10,38%	Ações
Telemark Asset Management, LLC	$8.692.889	3.846.411	7,19%	Ações
AMERIPRISE FINANCIAL INC	$8.609.334	3.809.440	7,12%	Ações
Nantahala Capital Management, LLC	$8.189.365	3.623.613	6,78%	Ações
VANGUARD CAPITAL MANAGEMENT LLC	$8.174.666	3.617.109	6,76%	Ações
GEODE CAPITAL MANAGEMENT, LLC	$4.204.899	1.860.140	3,48%	Ações
STATE STREET CORP	$3.970.400	1.756.814	3,29%	Ações
JACOBS LEVY EQUITY MANAGEMENT, INC	$3.006.263	1.330.205	2,49%	Ações
VANGUARD PORTFOLIO MANAGEMENT LLC	$2.954.206	1.307.171	2,44%	Ações
Assenagon Asset Management S.A.	$2.888.746	1.278.206	2,39%	Ações
D. E. Shaw & Co., Inc.	$2.500.229	1.106.296	2,07%	Ações
Tallon Kerry Patrick	$2.018.337	403.667	1,67%	Ações
TWO SIGMA INVESTMENTS, LP	$1.574.314	696.599	1,30%	Ações
FRANKLIN RESOURCES INC	$1.533.726	678.640	1,27%	Ações
VANGUARD FIDUCIARY TRUST CO	$1.313.191	581.058	1,09%	Ações
Man Group plc	$1.278.240	565.593	1,06%	Ações
Post Resch Tallon Group Inc.	$1.273.460	563.478	1,05%	Ações
PERKINS CAPITAL MANAGEMENT INC	$1.188.986	526.100	0,98%	Ações
ALGERT GLOBAL LLC	$973.857	430.910	0,81%	Ações
TUDOR INVESTMENT CORP ET AL	$808.910	357.925	0,67%	Ações
BlackRock, Inc.	$648.681	287.027	0,54%	Ações
PLATINUM INVESTMENT MANAGEMENT LTD	$597.689	264.464	0,49%	Ações
Potomac Capital Management, Inc.	$587.600	260.000	0,49%	Ações
DIMENSIONAL FUND ADVISORS LP	$583.674	258.263	0,48%	Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$547.397	242.211	0,45%	Ações
XTX Topco Ltd	$543.817	240.627	0,45%	Ações
UBS Group AG	$542.188	239.906	0,45%	Ações
FMR LLC	$457.501	202.434	0,38%	Ações
GOLDMAN SACHS GROUP INC	$389.726	172.445	0,32%	Ações
Cubist Systematic Strategies, LLC	$359.610	147.381	0,30%	Ações
BARCLAYS PLC	$347.740	153.867	0,29%	Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$334.595	148.051	0,28%	Ações
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$284.552	125.908	0,24%	Ações
STRS OHIO	$273.460	121.000	0,23%	Ações
JANE STREET GROUP, LLC	$261.857	115.866	0,22%	Ações
MARSHALL WACE, LLP	$254.791	112.739	0,21%	Ações
Stonepine Capital Management, LLC	$247.836	109.662	0,21%	Ações
RHUMBLINE ADVISERS	$233.449	103.301	0,19%	Ações
CITADEL ADVISORS LLC	$227.295	100.573	0,19%	Ações
ALLIANCEBERNSTEIN L.P.	$206.081	126.430	0,17%	Ações
WELLS FARGO & COMPANY/MN	$176.113	77.926	0,15%	Ações
Bank of New York Mellon Corp	$174.178	77.070	0,14%	Ações
LPL Financial LLC	$173.026	76.560	0,14%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$161.879	71.628	0,13%	Ações
BANK OF AMERICA CORP /DE/	$145.582	64.417	0,12%	Ações
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	$144.082	63.753	0,12%	Ações
Numerai GP LLC	$136.072	60.209	0,11%	Ações
PANAGORA ASSET MANAGEMENT INC	$131.532	58.200	0,11%	Ações
Mariner, LLC	$123.484	54.637	0,10%	Ações
MetLife Investment Management, LLC	$117.545	52.011	0,10%	Ações
ENVESTNET ASSET MANAGEMENT INC	$116.108	51.375	0,10%	Ações
LOS ANGELES CAPITAL MANAGEMENT LLC	$108.763	48.125	0,09%	Ações
IEQ CAPITAL, LLC	$104.559	46.265	0,09%	Ações
TWO SIGMA ADVISERS, LP	$96.822	59.400	0,08%	Ações
RENAISSANCE TECHNOLOGIES LLC	$93.790	41.500	0,08%	Ações
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$89.957	39.804	0,07%	Ações
CITIGROUP INC	$86.660	38.345	0,07%	Ações
Frec Markets, Inc.	$84.228	37.269	0,07%	Ações
OSAIC HOLDINGS, INC.	$82.186	36.366	0,07%	Ações
COMMONWEALTH EQUITY SERVICES, LLC	$81.820	36.204	0,07%	Ações
BANK OF MONTREAL /CAN/	$79.095	34.998	0,07%	Ações
Krilogy Financial LLC	$78.705	34.825	0,07%	Ações
MORGAN STANLEY	$77.462	34.275	0,06%	Ações
Invesco Ltd.	$77.181	34.151	0,06%	Ações
Dynamic Technology Lab Private Ltd	$74.000	33.000	0,06%	Ações
Vanguard Global Advisers, LLC	$73.681	32.602	0,06%	Ações
MERCER GLOBAL ADVISORS INC /ADV	$73.111	32.350	0,06%	Ações
AMERICAN CENTURY COMPANIES INC	$68.932	30.501	0,06%	Ações
BLAIR WILLIAM & CO/IL	$68.295	30.219	0,06%	Ações
EVERGREEN CAPITAL MANAGEMENT LLC	$65.540	29.000	0,05%	Ações
CWM, LLC	$63.696	39.077	0,05%	Ações
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	$61.418	25.275	0,05%	Ações
Nuveen Asset Management, LLC	$59.902	12.558	0,05%	Ações
PRUDENTIAL FINANCIAL INC	$59.619	26.380	0,05%	Ações
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$56.963	25.205	0,05%	Ações
Cerity Partners LLC	$53.695	23.759	0,04%	Ações
VANGUARD GROUP INC	$53.141	32.602	0,04%	Ações
INTECH INVESTMENT MANAGEMENT LLC	$48.486	21.454	0,04%	Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$45.426	20.100	0,04%	Opção de compra
Police & Firemen's Retirement System of New Jersey	$43.937	19.441	0,04%	Ações
VOYA INVESTMENT MANAGEMENT LLC	$41.948	18.561	0,03%	Ações
Vanguard Personalized Indexing Management, LLC	$40.562	17.948	0,03%	Ações
Simplicity Wealth,LLC	$39.410	17.438	0,03%	Ações
NEW YORK STATE COMMON RETIREMENT FUND	$38.167	16.888	0,03%	Ações
CITADEL ADVISORS LLC	$35.708	15.800	0,03%	Opção de compra
Creative Planning	$35.003	15.488	0,03%	Ações
BNP PARIBAS FINANCIAL MARKETS	$34.942	15.461	0,03%	Ações
Navalign, LLC	$34.668	15.340	0,03%	Ações
EP Wealth Advisors, LLC	$34.526	15.277	0,03%	Ações
China Universal Asset Management Co., Ltd.	$32.693	14.466	0,03%	Ações
ProShare Advisors LLC	$32.324	14.303	0,03%	Ações
Elmwood Wealth Management, Inc.	$28.691	12.695	0,02%	Ações
NORTHERN TRUST CORP	$27.992	12.386	0,02%	Ações
OXFORD ASSET MANAGEMENT LLP	$27.335	12.095	0,02%	Ações
Graham Capital Management, L.P.	$27.287	12.074	0,02%	Ações
Tower Research Capital LLC (TRC)	$27.244	12.055	0,02%	Ações
Abel Hall, LLC	$26.930	11.916	0,02%	Ações
Caerus Investment Advisors, LLC	$26.297	11.636	0,02%	Ações

Executivos da empresa 40 insiders · 19 diretores · 20 conselheiros

Investidor com informação privilegiada	Função	Última atividade	Ações detidas	Vendas 12m	Líquido 12m
John J Nicols	President and CEO	11 de Junho de 2018 M	1.072.679	0	$0
Peter M Strumph	Interim President and CEO	1 de Junho de 2012 A	60.756	0	$0
Alan Shaw	President and CEO	16 de Dezembro de 2011 S	202.000	0	$0
Georgia Erbez	Chief Financial Officer	5 de Fevereiro de 2025 A	76.875	0	$0
Sriram Ryali	Chief Financial Officer	1 de Janeiro de 2024 A	175.791	0	$0
Gordon Sangster	SVP & Chief Financial Officer	24 de Maio de 2018 S	153.189	0	$0
David D O'Toole	SVP & Chief Financial Officer	4 de Setembro de 2013 F	110.687	0	$0
Brian Paul Dowd	Interim CFO	1 de Junho de 2012 A	28.310	0	$0
Robert J Lawson	SVP and CFO	11 de Maio de 2011 P	44.000	0	$0
Kevin Norrett	Chief Operating Officer	5 de Fevereiro de 2025 A	177.327	0	$0
Alison Moore	Chief Technical Officer	5 de Fevereiro de 2025 A	175.571	0	$0
Margaret Nell Fitzgerald	Chief Legal and Compliance Officer	1 de Janeiro de 2024 A	133.770	0	$0
James Lalonde	SVP, R&D	17 de Julho de 2018 S	195.066	0	$0
Michael D. Aldridge	Senior Vice President, Corporate & Strategic Development	17 de Maio de 2018 M	0	0	$0
Douglas T. Sheehy	EVP, Chief Administrative Officer, General Counsel & Secretary	5 de Março de 2016 F	247.617	0	$0
Matthew Tobin	SVP, Research & Development	16 de Maio de 2013 M	78.707	0	$0
David L. Anton	SVP, BioIndustrials	10 de Fevereiro de 2013 F	93.777	0	$0
Seufer-Wasserthal Peter	SVP, Pharmaceuticals	24 de Janeiro de 2013 A	93.064	0	$0
Joseph J. Sarret	SVP and CBO	7 de Março de 2012 A	74.000	0	$0
Raymond De Vre	Conselheiro	17 de Junho de 2026 A	84.811	1	$-6.174
Esther Martinborough	Conselheiro	17 de Junho de 2026 A	129.036	0	$0
Christos Richards	Conselheiro	17 de Junho de 2026 A	85.133	0	$0
Cynthia Collins	Conselheiro	17 de Junho de 2026 A	112.157	0	$0
Stephen George Dilly	Conselheiro	17 de Junho de 2026 A	673.053	0	$0
Rahul Singhvi	Conselheiro	17 de Junho de 2026 A	137.052	0	$0
David V Smith	Conselheiro	17 de Junho de 2026 A	105.705	0	$0
PARKER H STEWART	Conselheiro	17 de Junho de 2026 A	143.583	0	$0
Dennis P Wolf	Conselheiro	10 de Junho de 2025 A	147.903	0	$0
Byron L Dorgan	Conselheiro	11 de Junho de 2024 A	223.581	0	$0
Patrick Y Yang	Conselheiro	19 de Julho de 2018 S	304.157	0	$0
Kathleen Sereda Glaub	Conselheiro	18 de Julho de 2018 S	98.120	0	$0
Thomas R Baruch	Conselheiro	26 de Junho de 2018 S	153.093	0	$0
Bernard J Kelley	Conselheiro	21 de Junho de 2018 S	225.668	0	$0
Pam P. Cheng	Conselheiro	11 de Junho de 2018 A	64.642	0	$0
Alexander Karsner	Conselheiro	2 de Janeiro de 2014 A	78.519	0	$0
Bruce A Pasternack	Conselheiro	24 de Agosto de 2010 P	10.000	0	$0
James R Sulat	Conselheiro	27 de Abril de 2010 J	5.957.108	0	$0
Brazil Holding B.V. Shell	Detentor de 10%	31 de Maio de 2011 J	5.573.319	0	$0
Equilon Enterprises LLC	Detentor de 10%	20 de Maio de 2011 J	5.573.319	0	$0
MAXYGEN INC	Detentor de 10%	14 de Dezembro de 2010 J	524.643	0	$0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 3 participações

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante	Declarado	Participação	Status	Propósito	Declaração
John Nicols	16 de Fevereiro de 2021	—	Declaração inicial	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 declarações	26 de Maio de 2015	—	Declaração inicial	—	SEC
– I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED	7 de Junho de 2011	—	Declaração inicial	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 26 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo	Peso	Unidades	Em	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,26%	40.370 SH	8 de Agosto de 2026	Diário
IWC · iShares Trust	0,03%	290.804 SH	8 de Agosto de 2026	Diário
BIB · ProShares Trust	0,01%	3.341 NS	31 de Maio de 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	496.936 SH	8 de Agosto de 2026	Diário
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	78.444 SH	8 de Agosto de 2026	Diário
IBB · iShares Trust	0,01%	613.531 SH	8 de Agosto de 2026	Diário
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	4.900 SH	8 de Agosto de 2026	Diário
RSSL · Global X Funds	0,01%	38.712 NS	30 de Abril de 2026	N-PORT
IWO · iShares Trust	0,01%	679.206 SH	8 de Agosto de 2026	Diário
ITWO · ProShares Trust	0,01%	4.198 NS	31 de Maio de 2026	N-PORT
IWM · iShares Trust	0,00%	2.240.076 SH	8 de Agosto de 2026	Diário
UWM · ProShares Trust	0,00%	3.283 NS	31 de Maio de 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,00%	71.405 SH	8 de Agosto de 2026	Diário
AVSC · AMERICAN CENTURY ETF TRUST	0,00%	28.868 NS	31 de Maio de 2026	N-PORT
URTY · ProShares Trust	0,00%	3.320 NS	31 de Maio de 2026	N-PORT
IWN · iShares Trust	0,00%	128.823 SH	8 de Agosto de 2026	Diário
HDG · ProShares Trust	0,00%	83 NS	31 de Maio de 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	52.788 NS	30 de Abril de 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,00%	2.554 NS	31 de Maio de 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	1.729 NS	30 de Abril de 2026	N-PORT
IWV · iShares Trust	0,00%	16.926 SH	8 de Agosto de 2026	Diário
DFAC · Dimensional ETF Trust	0,00%	19.277 NS	30 de Abril de 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	895.869 SH	8 de Agosto de 2026	Diário
VTI · VANGUARD INDEX FUNDS	0,00%	2.633.770 SH	8 de Agosto de 2026	Diário
VTWV · VANGUARD SCOTTSDALE FUNDS	0,00%	9.454 SH	8 de Agosto de 2026	Diário
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	6.744 SH	8 de Agosto de 2026	Diário

Sobre Codexis, Inc. - Common Stock Visão geral da empresa da Wikipedia

History

Pharmaceutical

Nutrition

Biotherapeutics

Life science

Technology

CDXS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

CDXS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Médias móveis e sobreposições

Volume

Osciladores

Momento e tendência

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

CDXS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

Preço-alvo de 12 meses

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

Investidores institucionais (13F) 156 declarantes · $120.9M total · Em 30 de Junho de 2026

Executivos da empresa 40 insiders · 19 diretores · 20 conselheiros

Ativistas e proprietários de 5%+ 3 participações

Participação em ETFs Detido por 26 ETFs